About Us
About Us
About Us
A Silent Epidemic Among Our Best Friends
A Silent Epidemic Among Our Best Friends
A Silent Epidemic Among Our Best Friends
Cancer is the #1 cause of death in dogs & cats. 1 in 4 dogs develop cancer in their lifetime and cancer causes nearly 50% of deaths in dogs over age 10.
Management
Management
Management
We believe in teamwork, creativity, and pushing boundaries to achieve excellence.
We believe in teamwork, creativity, and pushing boundaries to achieve excellence.
We believe in teamwork, creativity, and pushing boundaries to achieve excellence.
CEO
JØRUND SOLLID
Jørund Sollid is the Chief Executive Offier at Alv B. He holds a Ph.D. in physiology from the University of Oslo. Operational focused and strategy-driven executive and deal-maker with over 20 years of hands-on experience in various international and national roles, including corporate strategy, commercial operations, deal-making and strategic partnerships, within the pharmaceutical and biotech industry, e.g. Roche, Mundipharma, Lytix Biopharma and Servier.
CEO
JØRUND SOLLID
Jørund Sollid is the Chief Executive Offier at Alv B. He holds a Ph.D. in physiology from the University of Oslo. Operational focused and strategy-driven executive and deal-maker with over 20 years of hands-on experience in various international and national roles, including corporate strategy, commercial operations, deal-making and strategic partnerships, within the pharmaceutical and biotech industry, e.g. Roche, Mundipharma, Lytix Biopharma and Servier.
CEO
JØRUND SOLLID
Jørund Sollid is the Chief Executive Offier at Alv B. He holds a Ph.D. in physiology from the University of Oslo. Operational focused and strategy-driven executive and deal-maker with over 20 years of hands-on experience in various international and national roles, including corporate strategy, commercial operations, deal-making and strategic partnerships, within the pharmaceutical and biotech industry, e.g. Roche, Mundipharma, Lytix Biopharma and Servier.
CMO
Francesca Gatti
Francesca Gatti is the Chief Operating Officer at ALV B. She is a molecular and cellular biologist with a PhD in Biotechnology with focus on immunology and biomaterials, from the University of Salento in collaboration with Harvard Medical School. Since 2019 she has worked in biotechs developing solutions for molecular diagnostics of infectious diseases and cancer
CMO
Francesca Gatti
Francesca Gatti is the Chief Operating Officer at ALV B. She is a molecular and cellular biologist with a PhD in Biotechnology with focus on immunology and biomaterials, from the University of Salento in collaboration with Harvard Medical School. Since 2019 she has worked in biotechs developing solutions for molecular diagnostics of infectious diseases and cancer
CMO
Francesca Gatti
Francesca Gatti is the Chief Operating Officer at ALV B. She is a molecular and cellular biologist with a PhD in Biotechnology with focus on immunology and biomaterials, from the University of Salento in collaboration with Harvard Medical School. Since 2019 she has worked in biotechs developing solutions for molecular diagnostics of infectious diseases and cancer
HEAD OF CLINICAL
Lars Moe
Lars Moe is a former professor in internal medicine for small animals. He has more than 40 years' experience as a teacher, researcher, and leader in many aspects of veterinary science. His main research has been in clinical oncology, focusing on causation, including hereditary cancers, cancer epidemiology, diagnostics, and therapy. He has a broad collaboration experience with veterinary faculties and experts within the field around the globe.
HEAD OF CLINICAL
Lars Moe
Lars Moe is a former professor in internal medicine for small animals. He has more than 40 years' experience as a teacher, researcher, and leader in many aspects of veterinary science. His main research has been in clinical oncology, focusing on causation, including hereditary cancers, cancer epidemiology, diagnostics, and therapy. He has a broad collaboration experience with veterinary faculties and experts within the field around the globe.
HEAD OF CLINICAL
Lars Moe
Lars Moe is a former professor in internal medicine for small animals. He has more than 40 years' experience as a teacher, researcher, and leader in many aspects of veterinary science. His main research has been in clinical oncology, focusing on causation, including hereditary cancers, cancer epidemiology, diagnostics, and therapy. He has a broad collaboration experience with veterinary faculties and experts within the field around the globe.
R&D consultant
Mikael Kerboeuf
Mikael Kerboeuf is the Chief Scientific Officer at Alv B. He holds a Ph.D. degree in veterinary medicine from the Norwegian University of Life Sciences. His research is primarily centered on cancer metastasis and utilizing dogs as translational cancer models for human diseases. His expertise area is the link between the immune system and cancer metastasis.
R&D consultant
Mikael Kerboeuf
Mikael Kerboeuf is the Chief Scientific Officer at Alv B. He holds a Ph.D. degree in veterinary medicine from the Norwegian University of Life Sciences. His research is primarily centered on cancer metastasis and utilizing dogs as translational cancer models for human diseases. His expertise area is the link between the immune system and cancer metastasis.
R&D consultant
Mikael Kerboeuf
Mikael Kerboeuf is the Chief Scientific Officer at Alv B. He holds a Ph.D. degree in veterinary medicine from the Norwegian University of Life Sciences. His research is primarily centered on cancer metastasis and utilizing dogs as translational cancer models for human diseases. His expertise area is the link between the immune system and cancer metastasis.
Head Quality Control
NANDA TARTE
Nanda has PhD in Biotechnology from Mumbai University with circa 18 years of experience in Academic Research and Pharmaceutical Industry. She has extensively worked in Developing, Preparing Risk Assessment and HSE documentation, standardizing, and evaluating Standard Operating procedures based on Quality standards with 5 years of experience in this field. Nanda has excellent knowledge of biotechnological laboratory equipment, and experience in cell biology, bioinformation, immunology
Head Quality Control
NANDA TARTE
Nanda has PhD in Biotechnology from Mumbai University with circa 18 years of experience in Academic Research and Pharmaceutical Industry. She has extensively worked in Developing, Preparing Risk Assessment and HSE documentation, standardizing, and evaluating Standard Operating procedures based on Quality standards with 5 years of experience in this field. Nanda has excellent knowledge of biotechnological laboratory equipment, and experience in cell biology, bioinformation, immunology
Head Quality Control
NANDA TARTE
Nanda has PhD in Biotechnology from Mumbai University with circa 18 years of experience in Academic Research and Pharmaceutical Industry. She has extensively worked in Developing, Preparing Risk Assessment and HSE documentation, standardizing, and evaluating Standard Operating procedures based on Quality standards with 5 years of experience in this field. Nanda has excellent knowledge of biotechnological laboratory equipment, and experience in cell biology, bioinformation, immunology
CHIEF MARKETING OFFICER
JAKOB HØGH
CHIEF MARKETING OFFICER
JAKOB HØGH
CHIEF MARKETING OFFICER
JAKOB HØGH
Board of Directors
Board of Directors
Board of Directors
We believe in teamwork, creativity, and pushing boundaries to achieve excellence.
We believe in teamwork, creativity, and pushing boundaries to achieve excellence.
We believe in teamwork, creativity, and pushing boundaries to achieve excellence.
CHAIRMAN OF THE BOARD
MARCUS SAHLIN PETTERSEN
CHAIRMAN OF THE BOARD
MARCUS SAHLIN PETTERSEN
CHAIRMAN OF THE BOARD
MARCUS SAHLIN PETTERSEN
BOARD MEMBER
Christine Bjerke
BOARD MEMBER
Christine Bjerke
BOARD MEMBER
Christine Bjerke
BOARD MEMBER
CHRISTOFFER J. FALCHENBERG
BOARD MEMBER
CHRISTOFFER J. FALCHENBERG
BOARD MEMBER
CHRISTOFFER J. FALCHENBERG
BOARD MEMBER
Peter
BOARD MEMBER
Peter
BOARD MEMBER